// App-Quantinova.ai

Su1607 : Risk of Serious Upper Gastrointestinal (UGI) Complications With Concomitant Use of Non-Selective NSAIDs and Clopidogrel for At Least 4 Weeks: a Series of Systematic Reviews of Randomized Controlled Trials (RCT), Cohort Studies and Case Control Studies

Researchers

Presenter

  • Yuhong Yuan

Principal Investigators

  • Frances Tse

  • Richard H. Hunt

  • Paul Moayyedi

Medical Centers

  • Division of Urology, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Peptic ulcer

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved